| Document |
Document Title |
|
WO/2022/251169A1 |
Crystalline salts of psilocin are disclosed. The beneficial and therapeutic uses of the crystalline psilocin salts and of compositions containing the crystalline psilocin salts are also disclosed. The disclosure sets out methods of makin...
|
|
WO/2022/238389A2 |
The present disclosure relates to various crystalline forms of entinostat and to processes for their preparation, particularly Form A of entinostat compound with maleic acid, Form A of entinostat compound with succinic acid, Form B of en...
|
|
WO/2022/240920A1 |
Provided herein are cocrystalline forms including BTK-I useful in the treatment and prevention of diseases which can be treated with a BTK inhibitor, including BTK-associated diseases and disorders, characterizations, and methods of maki...
|
|
WO/2022/236127A1 |
Provided is a first process of producing an anhydride of an organic mono-acid comprising performing a transanhydridization reaction of an organic mono-acid and a thermally regenerable anhydride to produce the anhydride of the organic mon...
|
|
WO/2022/227668A1 |
A recovery method for lithium iron phosphate waste and an application. The method comprises the following steps: mixing lithium iron phosphate waste with water to make a slurry, adding alkali to adjust a pH until the slurry is alkaline, ...
|
|
WO/2022/204752A1 |
Disclosed herein is a method for producing iron (II) oxalate from an insoluble iron material, the method comprising digesting the insoluble iron material with a digestion liquor comprising one or more acids, and reacting digested iron sp...
|
|
WO/2022/194863A1 |
Process for obtaining dicarboxylic acids from a mixture of triglycerides of dicarboxylic acids comprising the steps of a) hydrolysing said mixture of triglycerides of dicarboxylic acids in the presence of a basic aqueous solution, result...
|
|
WO/2022/191314A1 |
The present invention makes it possible to produce adipic acid at a high selectivity without emitting dinitrogen monoxide by using a 3-hydroxyadipic acid 3,6-lactone composition as a starting material, the composition containing 3 to 30 ...
|
|
WO/2022/187235A1 |
In various embodiments, the present invention relates to a series 3D printable, biodegradable, poly(propylene fumarate) derivative ABA type triblock copolymers having a flexible propylene succinate core unit synthesized through ring-open...
|
|
WO/2022/174628A1 |
The invention relates to a method for co-producing adipic acid and cyclohexanone oxime from cyclohexane. The method comprises: (1) subjecting cyclohexane and NO x to oxidation nitration to generate adipic acid, nitrocyclohexane, a nitrog...
|
|
WO/2022/148797A1 |
Process for preparing potassium oxalate which process comprises contacting potassium formate with a base catalyst at a temperature of from 140 to 260°C which base catalyst is a metal hydride.
|
|
WO/2022/132694A1 |
A system for glucaric acid production, the system comprising: (a) a first input selected from the group consisting of glucuronolactone, a disaccharide feedstock, a cleaved starch, a disaccharide, glucuronic acid, or a combination thereof...
|
|
WO/2022/106549A1 |
The present invention relates to salt forms of the following compound (I).
|
|
WO/2022/107695A1 |
A method for producing barium titanyl oxalate, wherein barium titanyl oxalate is produced by mixing and reacting a solution containing oxalic acid (solution A) and a solution containing a titanium source and a barium source (solution B) ...
|
|
WO/2022/108435A1 |
The present invention relates to a method for transforming phosphogypsum, a waste produced by the phosphate industry, into high value-added products, namely ammonium sulphate and calcium oxalate.
|
|
WO/2022/101287A1 |
A method for generating a carboxylic acid from carbon dioxide (CO2), the method includes (a) feeding a gas stream having the CO2 to a first reactor having a base (MOH) to produce bicarbonate (MHCO3) and (b) feeding the MHCO3 generated in...
|
|
WO/2022/092851A1 |
The present invention relates to a method for preparing a hydrocarbon double acid with a cyclic hydrocarbon oxidation catalyst, wherein, in the presence of a vanadium phosphate oxide-based catalyst and/or a cobalt manganese oxide-based c...
|
|
WO/2022/069568A1 |
The present disclosure relates to a method for generating a hydrogel from a CO2 gas stream. The method for converting a CO2 gas stream comprising a CO2 into an ester, comprises the conversion of CO2 into a (COOH)2 preferably by passing t...
|
|
WO/2022/058785A1 |
The invention relates to new olaparib oxalic acid cocrystals. The olaparib oxalic acid cocrystals vary in ratio from 1:1 to 2:3 olaparib: oxalic acid. In particular, the invention relates to a 2:3 olaparib oxalic acid cocrystal, a 1:1 ol...
|
|
WO/2022/048662A1 |
Disclosed is a preparation method for a bio-based nylon 5X fiber material. The method comprises the following steps: 1) mixing a 1,5-pentanediamine mixed fermentation liquid and a dibasic acid for a polymerization reaction, obtaining a n...
|
|
WO/2022/040377A1 |
The present disclosure relates to methods of preparing compounds of Formula (VII) and salts thereof, and relates to compounds and combinations useful for the preparation. The present disclosure also relates to compounds being prepared by...
|
|
WO/2022/013767A1 |
A process for the purification of saturated linear aliphatic dicarboxylic acids, or mixtures thereof, obtained by biotechnological processes is described.
|
|
WO/2022/014234A1 |
Provided is a method for recovering high-purity scandium by effectively reducing impurity content of obtained scandium oxalate and reducing variation in impurity content. The present invention is a method that is for recovering scandiu...
|
|
WO/2021/251451A1 |
The present invention provides barium titanyl oxalate which makes it possible to obtain barium titanate that has a small particle size and that is highly crystalline. The present invention also provides a method for producing said barium...
|
|
WO/2021/231556A1 |
Processes for the oxidation of carbohydrate dehydration products, such as furanics that can be oxidized to the bio-based monomer 2,5-furandicarboxylic acid (FDCA), are disclosed, according to which certain co-feeds, having been discovere...
|
|
WO/2021/224303A2 |
According to a first aspect, the invention relates to a polyethylene-type polymer comprising methylene groups (CH2) and at least one functional group selected from group O-C(=O) and group O-C(=O)-O, the polyethylene-type polymer having a...
|
|
WO/2021/224063A1 |
The invention relates to a simple and efficient metal-free method for oxidative cleavage of vic-diols, in particular those derived from fatty esters, to the corresponding carboxylic acids, using a cheap, safe and environmentally friendly...
|
|
WO/2021/158666A1 |
The disclosure provides novel solid state forms of Compound (I) selected from Form B, citric acid cocrystal Form A, piperazine cocrystal Form A, urea cocrystal Form A, nicotinamide cocrystal Form A, nicotinamide cocrystal Form B, asparta...
|
|
WO/2021/140868A1 |
Provided is a means for controlling the molecular weight of a polyalkylene carbonate, when reacting a carbon dioxide with an epoxide to obtain a polyalkylene carbonate. More specifically, provided is an organozinc catalyst which is obtai...
|
|
WO/2021/127461A1 |
The present disclosure is directed synthetic methods for the preparation of 4-valyloxybutyric acid. The synthetic methods described herein employ a diverse array of protecting group strategies and reaction conditions. Additionally, the p...
|
|
WO/2021/119223A1 |
The present disclosure encompasses Lemborexant: succinic acid, a solid state form thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
|
|
WO/2021/108288A1 |
The present disclosure relates to amorphous and crystalline forms of (R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)c
yclohexyl)propanamide and its salts/cocrystals, solvates, and/or hydrates, processes for their production, ...
|
|
WO/2021/101867A1 |
The disclosure provides salts of (2R,6R)-hydroxynorketamine (HNK), wherein the salt is with an organic acid chosen from malonic acid, salicylic acid, ethane sulfonic acid, glycolic acid, stearic acid, or capric acid, and their crystal fo...
|
|
WO/2021/079973A1 |
Provided is an onium salt represented by general formula (1). (In general formula (1), X is any n-valent organic group selected from the group consisting of an aromatic group having 6-50 carbon atoms, a heteroaromatic group having 4-50 c...
|
|
WO/2021/060335A1 |
The present invention is characterized by comprising a step (hydrogenation step) for reacting 3-hydroxyadipic acid-3, 6-lactone with hydrogen in an aqueous solvent in the presence of a hydrogenation catalyst, and is able to produce adipi...
|
|
WO/2021/056850A1 |
Provided are an eutectic crystal formed by apixaban and a carboxylic acid, and a preparation method therefor. The eutectic crystal comprises an apixaban/malonic acid eutectic crystal, an apixaban/D‐malate eutectic crystal, an apixaban/...
|
|
WO/2021/027807A1 |
Disclosed is a method for preparing an azelaic acid. In particular, the preparation method does not use ozone. The above method for preparing an azelaic acid includes carrying out a decarboxylation reaction of tetracarboxylic acid in org...
|
|
WO/2021/023803A1 |
The presently claimed invention relates to a continuous process for the preparation of dicarboxylic acids, especially a continuous process for the preparation of sebacic acid.
|
|
WO/2021/016339A1 |
An improved chemical probe for the detection of the amino acid citrulline combines: 1) a reactive head formed of 1,3-dicarbonyl moiety that reacts with a citrulline side chain in an improved manner compared to currently used 1,2-dicarbon...
|
|
WO/2021/010368A1 |
An Me element-substituted organic acid titanyl barium powder that is Me element-substituted organic acid titanyl barium in which some of the Ba sites are substituted by an Me element (Me represents at least one selected from Ca, Sr, and ...
|
|
WO/2021/001457A1 |
The present invention relates to crystalline salt forms of (R)-2-amino-3-phenylpropylcarbamate and a process for their preparation. The invention also relates to a pharmaceutical composition comprising one or more of the crystalline salt...
|
|
WO/2020/251613A1 |
There is disclosed a process for the production of dodecanedioic acid and 11- aminoundecanoic acid, comprising: (1) reacting castor oil with a primary or secondary amine to form a amide; (2) isomerizing the amide in the presence of a cat...
|
|
WO/2020/242772A1 |
The present disclosure encompasses solid state forms of SAGE-217, in embodiments SAGE-217: Oxalic acid Co-crystal, processes for preparation thereof, and pharmaceutical compositions thereof.
|
|
WO/2020/239568A1 |
There is disclosed a salt of Formula III, a method for manufacturing thereof as well as uses thereof. ( Formula III ), wherein X is H or OH, Y is H or a cation selected from the group consisting of Li, Na and K, is a single bond or a dou...
|
|
WO/2020/214841A1 |
Salts of hexylamine, for example, hexylamine succinate and tri-hexylamine citrate and their method of production are described. The disclosure also relates to compositions comprises hexyalmine and the use of hexylamine for for reducing a...
|
|
WO/2020/202096A1 |
Aspects of the present application relate to amorphous Filgotinib maleate, its solid dispersion with at least one pharmaceutically acceptable excipients and pharmaceutical compositions thereof. Further aspects relate to processes for the...
|
|
WO/2020/196460A1 |
This carboxylic acid production method enables a carboxylic acid to be produced efficiently, the method comprising: a step (A) for filtering a carboxylic acid-containing fermentation liquid by passing the same through a nano-filtration m...
|
|
WO/2020/191140A1 |
The present invention is directed to selinexor co-crystal forms; more particularly to two co-crystal forms with succinic acid as the coformer and a co-crystal form with vanillin as the coformer. The present disclosure is also related to ...
|
|
WO/2020/156360A1 |
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydr...
|
|
WO/2020/150568A1 |
Methods for syntheses of organic acids from a-keto acids, including methods for syntheses of isotopically encriched organic acids from a-keto acids are disclosed. The isotopically enriched organic acids are useful, for example, in metabo...
|
